September 08, 2024 06:47 (IST)
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir
Mumbai/UNI: Hyderabad-based Laurus Labs Limited on Friday said that it has signed an agreement with MPP (Medicine Patent Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.
MSN Labs initiates Phase-III clinical trials for COVID-19 treatment drug
Hyderabad/UNI: MSN Laboratories Private Limited, the front-runner in introducing various drugs in the treatment of COVID-19 and its complications, on Tuesday announced that it is initiating phase III clinical trials of ‘Molnupiravir’ capsules for the treatment of COVID-19 in India.
Latest Headlines
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir Fri, Jan 21 2022